Localization of glycosaminoglycan substitution sites on domain V of mouse perlecan
- PMID: 10600481
- DOI: 10.1006/bbrc.1999.1714
Localization of glycosaminoglycan substitution sites on domain V of mouse perlecan
Abstract
Perlecan, the predominant basement membrane proteoglycan, has previously been shown to contain glycosaminoglycans attached at serine residues, numbers 65, 71, and 76, in domain I. However, the C-terminal domains IV and V of this molecule may also be substituted with glycosaminoglycan chains, but the exact substitution sites were not identified. The amino acid sequence of mouse perlecan reveals many ser-gly sequences in these domains that are possible sites for glycosaminoglycan substitution. We expressed recombinant domain IV and/or V of mouse perlecan in COS-7 cells and analyzed glycosaminoglycan substitution. Both heparan sulfate and chondroitin sulfate chains could be detected on recombinant domain V. One site, ser-gly-glu (serine residue 3593), toward the C-terminal region of domain V is a substitution site for heparan sulfate. When this sequence was absent, chondroitin/dermatan sulfate substitution was deleted, and the likely site for this galactosaminoglycan substitution was ser-gly-ala-gly (serine residue 3250) on domain V.
Copyright 1999 Academic Press.
Similar articles
-
Border patrol: insights into the unique role of perlecan/heparan sulfate proteoglycan 2 at cell and tissue borders.Matrix Biol. 2014 Feb;34:64-79. doi: 10.1016/j.matbio.2013.08.004. Epub 2013 Aug 31. Matrix Biol. 2014. PMID: 24001398 Free PMC article. Review.
-
Formation of heparan sulfate or chondroitin/dermatan sulfate on recombinant domain I of mouse perlecan expressed in Chinese hamster ovary cells.Biochem Biophys Res Commun. 1995 Jun 6;211(1):262-7. doi: 10.1006/bbrc.1995.1805. Biochem Biophys Res Commun. 1995. PMID: 7779094
-
Structural basis of glycosaminoglycan modification and of heterotypic interactions of perlecan domain V.J Mol Biol. 1999 Nov 19;294(1):259-70. doi: 10.1006/jmbi.1999.3259. J Mol Biol. 1999. PMID: 10556044
-
Expression of human perlecan domain I as a recombinant heparan sulfate proteoglycan with 20-kDa glycosaminoglycan chains.Biochem Biophys Res Commun. 1999 Mar 24;256(3):542-8. doi: 10.1006/bbrc.1999.0377. Biochem Biophys Res Commun. 1999. PMID: 10080934
-
The biology of perlecan: the multifaceted heparan sulphate proteoglycan of basement membranes and pericellular matrices.Biochem J. 1994 Sep 15;302 ( Pt 3)(Pt 3):625-39. doi: 10.1042/bj3020625. Biochem J. 1994. PMID: 7945186 Free PMC article. Review. No abstract available.
Cited by
-
Border patrol: insights into the unique role of perlecan/heparan sulfate proteoglycan 2 at cell and tissue borders.Matrix Biol. 2014 Feb;34:64-79. doi: 10.1016/j.matbio.2013.08.004. Epub 2013 Aug 31. Matrix Biol. 2014. PMID: 24001398 Free PMC article. Review.
-
Novel interactions of perlecan: unraveling perlecan's role in angiogenesis.Microsc Res Tech. 2008 May;71(5):339-48. doi: 10.1002/jemt.20562. Microsc Res Tech. 2008. PMID: 18300285 Free PMC article. Review.
-
Collagen type IV and Perlecan exhibit dynamic localization in the Allantoic Core Domain, a putative stem cell niche in the murine allantois.Dev Dyn. 2009 Dec;238(12):3193-204. doi: 10.1002/dvdy.22129. Dev Dyn. 2009. PMID: 19924818 Free PMC article.
-
The glycosaminoglycan chains of perlecan regulate the perivascular fluid transport.Fluids Barriers CNS. 2025 May 8;22(1):48. doi: 10.1186/s12987-025-00648-7. Fluids Barriers CNS. 2025. PMID: 40340918 Free PMC article.
-
Mast cells produce novel shorter forms of perlecan that contain functional endorepellin: a role in angiogenesis and wound healing.J Biol Chem. 2013 Feb 1;288(5):3289-304. doi: 10.1074/jbc.M112.387811. Epub 2012 Dec 12. J Biol Chem. 2013. PMID: 23235151 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Molecular Biology Databases